ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "Cardiovascular Systems, Inc." (CSII) Report Updated: Apr 14, 2014 | Print This Page

Get more stock ratings by Louis Navellier

"Cardiovascular Systems, Inc." (CSII)

Rating: Buy Volatility: Moderate
Total Grade: B Industry: Health Care Equipment & Supplies
Competitors: DHRM, ATRI, LMAT, ANIK

Stock Analysis

Rating: Monthly View

A
B
C
D
F
April May June July August September October November December January February March

Rating: Weekly View

This Week: B down no change
Last Week: B same no change
Two Weeks Ago: B up no change
service keys

"Cardiovascular Systems, Inc."© quotemedia

Company Profile

Cardiovascular Systems, Inc., a medical device company, focuses on developing and commercializing minimally invasive treatment solutions for vascular disease. Its primary products include catheter-based platforms, such as the Stealth 360 peripheral artery disease (PAD) System, Diamondback 360 PAD System, and Diamondback Predator 360 PAD System that are used for the treatment of a range of plaque types in leg arteries above and below the knee. The company markets and sells its products through direct sales force to hospitals and office-based laboratories in the United States. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

Recent News: "Cardiovascular Systems, Inc."